PD1-VAXX killed a patient (as a single agent) and then they rushed through to phase 1B combination dosing (which they've now terminated early).
At least the "CHM losers" have a chance at some upside. You won't get $20m for the B Cell platform. IMU currently worth ~$150m (including the rapidly depleting cash on hand) and only if you're lucky.
A long way to fall yet.
IMU Price at posting:
3.7¢ Sentiment: Sell Disclosure: Not Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)